Céline Bourguignon has a track record of more than 25 years in the healthcare sector at European and international level both in the public and the private sector.
Céline joined GSK in 2021 to lead the Greater China and Intercontinental & Emerging Market Regulatory Policy team and is supporting global regulatory policies on Reliance and on drug device combination and in vitro diagnostics including Companion diagnostics.
She joins from Cardinal Health where she served during the last three years as head of Quality, Regulatory and Clinical Affairs for the EMEA region, and as a member of the European Leadership team. In this role she had oversight of clinical trials, regulatory submissions and approval across 30+ countries.
Previously, Céline held various positions in Johnson & Johnson, in Regulatory Affairs, Government Affairs and Regulatory Policy, building the global enterprise strategy on environmental regulatory policy and supporting the company engagement on regulatory harmonization at global level.
Céline joined the European Commission (EC) in 2008, working as a policy officer in the medical devices and in vitro diagnostics unit, after a ten year-period involvement as hospital pharmacist and as a reviewer for the French Competent Authorities. Céline held various Chair or Vice-Chair positions within Medtech Europe (Eudamed, UDI & Supply chain, Regulatory Affairs Committee) and EFPIA.
She is a former board member of the Avicenna Alliance and represented the EC in the In Vitro Diagnostic Global Harmonization Taskforce working group and in expert groups during bilateral discussions.
Session objectives:
